Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 103

1.

Effects of pioglitazone on insulin sensitivity and serum lipids in obese cats.

Clark M, Thomaseth K, Dirikolu L, Ferguson DC, Hoenig M.

J Vet Intern Med. 2014 Jan-Feb;28(1):166-74.

PMID:
24592408
[PubMed - indexed for MEDLINE]
2.

Effect of darglitazone on glucose clearance and lipid metabolism in obese cats.

Hoenig M, Ferguson DC.

Am J Vet Res. 2003 Nov;64(11):1409-13.

PMID:
14620778
[PubMed - indexed for MEDLINE]
3.

Pharmacokinetics of pioglitazone in lean and obese cats.

Clark MH, Hoenig M, Ferguson DC, Dirikolu L.

J Vet Pharmacol Ther. 2012 Oct;35(5):428-36. doi: 10.1111/j.1365-2885.2011.01341.x. Epub 2012 May 21.

PMID:
22612529
[PubMed - indexed for MEDLINE]
4.

Importance of changes in adipose tissue insulin resistance to histological response during thiazolidinedione treatment of patients with nonalcoholic steatohepatitis.

Gastaldelli A, Harrison SA, Belfort-Aguilar R, Hardies LJ, Balas B, Schenker S, Cusi K.

Hepatology. 2009 Oct;50(4):1087-93. doi: 10.1002/hep.23116.

PMID:
19670459
[PubMed - indexed for MEDLINE]
5.

A randomized, double-blind, placebo-controlled, clinical trial of the effects of pioglitazone on glycemic control and dyslipidemia in oral antihyperglycemic medication-naive patients with type 2 diabetes mellitus.

Herz M, Johns D, Reviriego J, Grossman LD, Godin C, Duran S, Hawkins F, Lochnan H, Escobar-Jiménez F, Hardin PA, Konkoy CS, Tan MH.

Clin Ther. 2003 Apr;25(4):1074-95.

PMID:
12809958
[PubMed - indexed for MEDLINE]
6.

Effect of pioglitazone on circulating adipocytokine levels and insulin sensitivity in type 2 diabetic patients.

Miyazaki Y, Mahankali A, Wajcberg E, Bajaj M, Mandarino LJ, DeFronzo RA.

J Clin Endocrinol Metab. 2004 Sep;89(9):4312-9.

PMID:
15356026
[PubMed - indexed for MEDLINE]
7.

Short-term pioglitazone treatment improves vascular function irrespective of metabolic changes in patients with type 2 diabetes.

Martens FM, Visseren FL, de Koning EJ, Rabelink TJ.

J Cardiovasc Pharmacol. 2005 Dec;46(6):773-8.

PMID:
16306801
[PubMed - indexed for MEDLINE]
8.

Pioglitazone ameliorates insulin resistance and diabetes by both adiponectin-dependent and -independent pathways.

Kubota N, Terauchi Y, Kubota T, Kumagai H, Itoh S, Satoh H, Yano W, Ogata H, Tokuyama K, Takamoto I, Mineyama T, Ishikawa M, Moroi M, Sugi K, Yamauchi T, Ueki K, Tobe K, Noda T, Nagai R, Kadowaki T.

J Biol Chem. 2006 Mar 31;281(13):8748-55. Epub 2006 Jan 23.

PMID:
16431926
[PubMed - indexed for MEDLINE]
Free Article
9.

Rosiglitazone and pioglitazone similarly improve insulin sensitivity and secretion, glucose tolerance and adipocytokines in type 2 diabetic patients.

Miyazaki Y, DeFronzo RA.

Diabetes Obes Metab. 2008 Dec;10(12):1204-11. doi: 10.1111/j.1463-1326.2008.00880.x. Epub 2008 May 12.

PMID:
18476983
[PubMed - indexed for MEDLINE]
10.

The impact of pioglitazone on glycemic control and atherogenic dyslipidemia in patients with type 2 diabetes mellitus.

Rosenblatt S, Miskin B, Glazer NB, Prince MJ, Robertson KE; Pioglitazone 026 Study Group.

Coron Artery Dis. 2001 Aug;12(5):413-23.

PMID:
11491207
[PubMed - indexed for MEDLINE]
11.

Sibutramine effect on metabolic control of obese patients with type 2 diabetes mellitus treated with pioglitazone.

Derosa G, D'Angelo A, Salvadeo SA, Ferrari I, Gravina A, Fogari E, Maffioli P, Cicero AF.

Metabolism. 2008 Nov;57(11):1552-7. doi: 10.1016/j.metabol.2008.06.010.

PMID:
18940393
[PubMed - indexed for MEDLINE]
12.

Effect of pioglitazone on the metabolic and hormonal response to a mixed meal in type II diabetes.

Gastaldelli A, Casolaro A, Pettiti M, Nannipieri M, Ciociaro D, Frascerra S, Buzzigoli E, Baldi S, Mari A, Ferrannini E.

Clin Pharmacol Ther. 2007 Feb;81(2):205-12.

PMID:
17259945
[PubMed - indexed for MEDLINE]
13.

The ratio of leptin to adiponectin can be used as an index of insulin resistance.

Oda N, Imamura S, Fujita T, Uchida Y, Inagaki K, Kakizawa H, Hayakawa N, Suzuki A, Takeda J, Horikawa Y, Itoh M.

Metabolism. 2008 Feb;57(2):268-73. doi: 10.1016/j.metabol.2007.09.011.

PMID:
18191059
[PubMed - indexed for MEDLINE]
14.

Improved glycemic control and enhanced insulin sensitivity in type 2 diabetic subjects treated with pioglitazone.

Miyazaki Y, Mahankali A, Matsuda M, Glass L, Mahankali S, Ferrannini E, Cusi K, Mandarino LJ, DeFronzo RA.

Diabetes Care. 2001 Apr;24(4):710-9.

PMID:
11315836
[PubMed - indexed for MEDLINE]
15.

Chronic treatment with pioglitazone does not protect obese patients with diabetes mellitus type II from free fatty acid-induced insulin resistance.

Serlie MJ, Allick G, Groener JE, Ackermans MT, Heijligenberg R, Voermans BC, Aerts JM, Meijer AJ, Sauerwein HP.

J Clin Endocrinol Metab. 2007 Jan;92(1):166-71. Epub 2006 Oct 24.

PMID:
17062758
[PubMed - indexed for MEDLINE]
16.

Effects of obesity on lipid profiles in neutered male and female cats.

Hoenig M, Wilkins C, Holson JC, Ferguson DC.

Am J Vet Res. 2003 Mar;64(3):299-303.

PMID:
12661869
[PubMed - indexed for MEDLINE]
17.

Effect of omega-3 fatty acids on serum concentrations of adipokines in healthy cats.

Mazaki-Tovi M, Abood SK, Schenck PA.

Am J Vet Res. 2011 Sep;72(9):1259-65. doi: 10.2460/ajvr.72.9.1259.

PMID:
21879986
[PubMed - indexed for MEDLINE]
18.

Effects of pioglitazone and glimepiride on glycemic control and insulin sensitivity in Mexican patients with type 2 diabetes mellitus: A multicenter, randomized, double-blind, parallel-group trial.

Tan M, Johns D, González Gálvez G, Antúnez O, Fabián G, Flores-Lozano F, Zúñiga Guajardo S, Garza E, Morales H, Konkoy C, Herz M; GLAD Study Group.

Clin Ther. 2004 May;26(5):680-93.

PMID:
15220012
[PubMed - indexed for MEDLINE]
19.

Effects of pioglitazone versus glimepiride exposure on hepatocellular fat content in type 2 diabetes.

Phielix E, Brehm A, Bernroider E, Krssak M, Anderwald CH, Krebs M, Schmid AI, Nowotny P, Roden M.

Diabetes Obes Metab. 2013 Oct;15(10):915-22. doi: 10.1111/dom.12112. Epub 2013 May 1.

PMID:
23574533
[PubMed - indexed for MEDLINE]
20.

Pioglitazone increases insulin sensitivity, reduces blood glucose, insulin, and lipid levels, and lowers blood pressure, in obese, insulin-resistant rhesus monkeys.

Kemnitz JW, Elson DF, Roecker EB, Baum ST, Bergman RN, Meglasson MD.

Diabetes. 1994 Feb;43(2):204-11.

PMID:
8288044
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk